基于CT影像组学的胰腺导管腺癌术前生存预测
本研究回顾性纳入153例手术切除的胰腺导管腺癌患者,利用术前CT提取肿瘤及胰腺背景的影像组学特征,构建随机生存森林模型预测术后生存。10个最相关影像组学特征对高风险与低风险分组的分类准确率为82.2%。在临床参数基础上加入CT影像组学特征,C-index从0.6785提升至0.7414。
要点
- 术前CT影像组学特征可辅助预测胰腺导管腺癌术后生存。
- 10个影像组学特征对高低风险分组的分类准确率为82.2%。
- 影像组学加入临床参数后C-index由0.6785升至0.7414。
核心结论
- 在标准临床因素基础上加入CT影像组学特征可改善胰腺导管腺癌患者的生存预测。
研究设计与样本
- 回顾性研究,纳入153例2011至2017年间接受手术切除且术前行CT检查的胰腺导管腺癌患者。
- 手动分割全胰腺肿瘤及背景胰腺的3D体积,从肿瘤提取478个影像组学特征,并从胰腺边界计算11个额外特征。
- 通过特征降维选出10个最相关特征,采用随机生存森林算法估计生存状态和时间,以C-index评价模型性能。
诊断标准与关键数值
- 以术后生存时间分层:低风险组生存时间>3年,高风险组生存时间<1年。
- 10个最相关影像组学特征对高风险与低风险分组的分类准确率为82.2%。
- 仅用临床参数的生存预测C-index为0.6785,加入CT影像组学特征后C-index为0.7414。
临床应用与阅片要点
- 阅片时可关注肿瘤及背景胰腺的影像组学特征,结合临床因素进行术后生存风险分层。
- 影像组学特征需基于手动分割的肿瘤和胰腺3D体积提取,注意分割一致性对结果的影响。
局限性
- 回顾性单中心研究,样本量153例,结论需外部验证。
- 原文未报告影像组学特征的具体名称及模型校准等细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE. Pancreatic ductal adenocarcinoma (PDAC) is often a lethal malignancy with limited preoperative predictors of long-term survival. The purpose of this study was to evaluate the prognostic utility of preoperative CT radiomics features in predicting postoperative survival of patients with PDAC. MATERIALS AND METHODS. A total of 153 patients with surgically resected PDAC who underwent preoperative CT between 2011 and 2017 were retrospectively identified. Demographic, clinical, and survival information was collected from the medical records. Survival time after the surgical resection was used to stratify patients into a low-risk group (survival time > 3 years) and a high-risk group (survival time < 1 year). The 3D volume of the whole pancreatic tumor and background pancreas were manually segmented. A total of 478 radiomics features were extracted from tumors and 11 extra features were computed from pancreas boundaries. The 10 most relevant features were selected by feature reduction. Survival analysis was performed on the basis of clinical parameters both with and without the addition of the selected features. Survival status and time were estimated by a random survival forest algorithm. Concordance index (C-index) was used to evaluate performance of the survival prediction model. RESULTS. The mean age of patients with PDAC was 67 ± 11 (SD) years. The mean tumor size was 3.31 ± 2.55 cm. The 10 most relevant radiomics features showed 82.2% accuracy in the classification of high-risk versus low-risk groups. The C-index of survival prediction with clinical parameters alone was 0.6785. The addition of CT radiomics features improved the C-index to 0.7414. CONCLUSION. Addition of CT radiomics features to standard clinical factors improves survival prediction in patients with PDAC.
引用
- Park S, Sham JG, Kawamoto S, et al. CT Radiomics-Based Preoperative Survival Prediction in Patients With Pancreatic Ductal Adenocarcinoma. AJR Am J Roentgenol. 2021. PMID: 34467768. doi:10.2214/AJR.20.23490
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。